Director Global Medical Affairs Oncology (GMA) (m/f/x)

Passion for Innovation. Compassion for Patients.

With over 120 years of experience and more than 17,000 employees in over 20 countries, Daiichi Sankyo is dedicated to discovering, developing, and delivering new standards of care that enrich the quality of life around the world.

In Europe, we focus on two areas: The goal of our Specialty Business is to protect people from cardiovascular disease, the leading cause of death in Europe, and help patients who suffer from it to enjoy every precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel therapies for people with cancer.

Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries and Canada.

For our headquarters in all Europe we are seeking highly qualified candidates to fill the position:

Director Global Medical Affairs Oncology (GMA) (m/f/x)

The Position:

The Director Global Medical Affairs Oncology (GMA) (m/f/x), ADC, under the direction of the Senior Director, GMA Oncology ADC (Global Medical Affairs team lead for compound), is responsible for assisting with defining compound/program medical strategies and for leading select medical affairs projects within a specific compound or indication.

Responsibilities:

• Leads the development of the Global Medical Affairs strategy and execution of the Global Medical Affairs plan for select indications/projects related to evidence generation, medical information and internal education, publications, scientific exchange and external data communication, and stakeholder scientific engagement. Responsible for managing budgets and resources for the assigned GMA plan activities, in collaboration with Sr Director.
• Leads medical readiness activities for market launches and life cycle management for select indications/projects. Gains strategic and planning alignment across regions and functions and supports review of Local Country/Regional Medical Affairs activities when applicable. Provide medical support/input into commercial and market access discussions for select indications.
• Serve as medical lead for select company-sponsored GMA evidence generating studies/projects. Manages all medical aspects such as study document development and drives execution for assigned projects in collaboration with GMA Clinical Operations and other cross-functional and regional stakeholders.
• Provides support in review of investigator-initiated studies (IIS) and may serve as deputy compound lead in Global IIS Review Committee meetings.
• Leads external medical education and other scientific exchange activities in alignment with the Senior Director, such as scientific symposium and medical congresses, within legal and compliance regulations.
• Collaborates across functions to support GMA MI&E activities in order to achieve approval of key scientific communications resources such as medical information response documents, (non-) promotional materials, educational slide deck and other internal training resources, within legal and compliance regulations. Provide training or communication of emerging data (internal or competitive), such as congress updates and development program highlights.
• Provides medical leadership in interactions with key external stakeholders and lead Scientific Engagement activities such as planning advisory boards, managing individual stakeholder interactions and peer to peer discussions, congress engagement activities, and collation of insights for select indications related to the compound.
• Provides support in the review of GMA Publications (abstracts, presentations, and manuscripts) an may serve as deputy compound lead on the Publication Planning Subteam (PPS).

Personal Skills and professional experience:

• An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/ scientific area is required. Experience in oncology therapeutic area is required
• 10 or More Years overall relevant experience would be a plus
• 4 or More Years experience in pharma at local, regional and/or Global level is preferred
• Excellent knowledge of current clinical practice in Oncology / Hematology / Endocrinology or other relevant disease area
• knowledge in and understanding of medical activities (including scientific communications, medical information, MSLs, and HEOR), relating to the commercialization of oncology products
• Demonstrates strong scientific expertise within assigned therapeutic area(s) within the franchise
• Effectively manages activities and optimize resources and budget to meet business needs; have excellent project management skills
• Build strong internal and external relationships with diverse stakeholders to maximize alignment and organizational effectiveness
• Conduct medical/legal review
• Operational knowledge and experience in prospective and/or retrospective study design and all stages of study conduct (Start-up, Execution, Analysis, Reporting)
• Effectively engage external stakeholders across a broad range of audiences and activities such as evidence generation projects, publications, medical information and education, Advisory Boards, Scientific Exchange)
• Provide training to internal customers
• Review scientific communications resources and publications
• Expertly manage ambiguity and highly complex situations
• Have excellent communications skills and ability to convey complex scientific concepts simply and effectively
• Internal Project and Budget Accountability
• Fluent English (oral and written)

Why work with us?

Working at Daiichi Sankyo is more than just a job – it is your chance to make a difference and change patients’ lives for the better. We can only achieve this ambitious goal together. That is why we foster a culture of mutual respect and continuous learning, with a strong commitment to inclusion and diversity. Here, you will have the opportunity to grow, think boldly, and contribute your ideas. If you have a proactive mindset and passion for addressing the needs of patients, we eagerly await your application.

For more information: www.daiichi-sankyo.eu